Results

Reset All Filters

Manufacturer:DCChemicals remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Appl.	Item no.	Amount	Price
NF-κΒ activator 1	Inhibitors	Other		DCC-DC42357-100mg DCChemicals	100 mg	Login Compare	NF-κΒ activator 1
Lorcaserin	Chemicals	Other	IS	DCC-DC1011-50mg DCChemicals	50 mg	Login Compare	Lorcaserin
MMP-1/MMP-9 Fluorogenic Substrate	Chemicals	Other	other	DCC-DC11348-100mg DCChemicals	100 mg	Login Compare	MMP-1/MMP-9 Fluorogenic Substrate
CD73 inhibitor AB-680	Inhibitors	Other	IC	DCC-DC21981-100mg DCChemicals	100 mg	Login Compare	CD73 inhibitor AB-680
CD73 inhibitor AB-680	Inhibitors	Other	IC	DCC-DC21981-250mg DCChemicals	250 mg	Login Compare	CD73 inhibitor AB-680
CD73 inhibitor AB-680	Inhibitors	Other	IC	DCC-DC21981-1g DCChemicals	1 g	Login Compare	CD73 inhibitor AB-680
Complement factor D-IN-2	Chemicals	Other	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.	DCC-DC44151-100mg DCChemicals	100 mg	Login Compare	Complement factor D-IN-2
Complement factor D-IN-2	Chemicals	Other	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.	DCC-DC44151-250mg DCChemicals	250 mg	Login Compare	Complement factor D-IN-2
Complement factor D-IN-2	Chemicals	Other	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.	DCC-DC44151-1g DCChemicals	1 g	Login Compare	Complement factor D-IN-2
SIRT6 activator 12q	Chemicals	Other	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model	DCC-DC42568-100mg DCChemicals	100 mg	Login Compare	SIRT6 activator 12q
SIRT6 activator 12q	Chemicals	Other	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model	DCC-DC42568-250mg DCChemicals	250 mg	Login Compare	SIRT6 activator 12q
SIRT6 activator 12q	Chemicals	Other	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model	DCC-DC42568-1g DCChemicals	1 g	Login Compare	SIRT6 activator 12q
Moclobemide N-Oxide	Chemicals	Other		DCC-DC66432-100mg DCChemicals	100 mg	Login Compare	Moclobemide N-Oxide
Moclobemide N-Oxide	Chemicals	Other		DCC-DC66432-250mg DCChemicals	250 mg	Login Compare	Moclobemide N-Oxide
Moclobemide N-Oxide	Chemicals	Other		DCC-DC66432-1g DCChemicals	1 g	Login Compare	Moclobemide N-Oxide
Arginase inhibitor 1	Inhibitors	Other	IC	DCC-DC50092-100mg DCChemicals	100 mg	Login Compare	Arginase inhibitor 1
Arginase inhibitor 1	Inhibitors	Other	IC	DCC-DC50092-250mg DCChemicals	250 mg	Login Compare	Arginase inhibitor 1
Arginase inhibitor 1	Inhibitors	Other	IC	DCC-DC50092-1g DCChemicals	1 g	Login Compare	Arginase inhibitor 1
Indacaterol	Chemicals	Other	other	DCC-DC8914-100mg DCChemicals	100 mg	Login Compare	Indacaterol
Indacaterol	Chemicals	Other	other	DCC-DC8914-250mg DCChemicals	250 mg	Login Compare	Indacaterol
Glucocorticoid receptor modulator-1	Chemicals	Other	A novel Glucocorticoid receptor modulator.	DCC-DC57060-5mg DCChemicals	5 mg	Login Compare	Glucocorticoid receptor modulator-1
Potassium Channel Activator 1	Chemicals	Other	other	DCC-DC60282-100mg DCChemicals	100 mg	Login Compare	Potassium Channel Activator 1
Potassium Channel Activator 1	Chemicals	Other	other	DCC-DC60282-250mg DCChemicals	250 mg	Login Compare	Potassium Channel Activator 1
Potassium Channel Activator 1	Chemicals	Other	other	DCC-DC60282-1g DCChemicals	1 g	Login Compare	Potassium Channel Activator 1
L-Methionine sulfoxide	Chemicals	Other	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.	DCC-DC29170-100mg DCChemicals	100 mg	Login Compare	L-Methionine sulfoxide

Name Price

NF-κΒ activator 1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC42357-100mg
Amount	100 mg
Available

Lorcaserin

Type	Chemicals
Clone
Specific against	Other
Appl.	IS
Host
Item no.	DCC-DC1011-50mg
Amount	50 mg
Available

MMP-1/MMP-9 Fluorogenic Substrate

Type	Chemicals
Clone
Specific against	Other
Appl.	other
Host
Item no.	DCC-DC11348-100mg
Amount	100 mg
Available

CD73 inhibitor AB-680

Type	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
Item no.	DCC-DC21981-100mg
Amount	100 mg
Available

CD73 inhibitor AB-680

Type	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
Item no.	DCC-DC21981-250mg
Amount	250 mg
Available

CD73 inhibitor AB-680

Type	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
Item no.	DCC-DC21981-1g
Amount	1 g
Available

Complement factor D-IN-2

Type	Chemicals
Clone
Specific against	Other
Appl.	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.
Host
Item no.	DCC-DC44151-100mg
Amount	100 mg
Available

Complement factor D-IN-2

Type	Chemicals
Clone
Specific against	Other
Appl.	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.
Host
Item no.	DCC-DC44151-250mg
Amount	250 mg
Available

Complement factor D-IN-2

Type	Chemicals
Clone
Specific against	Other
Appl.	Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases.
Host
Item no.	DCC-DC44151-1g
Amount	1 g
Available

SIRT6 activator 12q

Type	Chemicals
Clone
Specific against	Other
Appl.	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model
Host
Item no.	DCC-DC42568-100mg
Amount	100 mg
Available

SIRT6 activator 12q

Type	Chemicals
Clone
Specific against	Other
Appl.	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model
Host
Item no.	DCC-DC42568-250mg
Amount	250 mg
Available

SIRT6 activator 12q

Type	Chemicals
Clone
Specific against	Other
Appl.	Novel SIRT6 activator, significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model
Host
Item no.	DCC-DC42568-1g
Amount	1 g
Available

Moclobemide N-Oxide

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC66432-100mg
Amount	100 mg
Available

Moclobemide N-Oxide

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC66432-250mg
Amount	250 mg
Available

Moclobemide N-Oxide

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC66432-1g
Amount	1 g
Available

Arginase inhibitor 1

Type	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
Item no.	DCC-DC50092-100mg
Amount	100 mg
Available

Arginase inhibitor 1

Type	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
Item no.	DCC-DC50092-250mg
Amount	250 mg
Available

Arginase inhibitor 1

Type	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
Item no.	DCC-DC50092-1g
Amount	1 g
Available

Indacaterol

Type	Chemicals
Clone
Specific against	Other
Appl.	other
Host
Item no.	DCC-DC8914-100mg
Amount	100 mg
Available

Indacaterol

Type	Chemicals
Clone
Specific against	Other
Appl.	other
Host
Item no.	DCC-DC8914-250mg
Amount	250 mg
Available

Glucocorticoid receptor modulator-1

Type	Chemicals
Clone
Specific against	Other
Appl.	A novel Glucocorticoid receptor modulator.
Host
Item no.	DCC-DC57060-5mg
Amount	5 mg
Available

Potassium Channel Activator 1

Type	Chemicals
Clone
Specific against	Other
Appl.	other
Host
Item no.	DCC-DC60282-100mg
Amount	100 mg
Available

Potassium Channel Activator 1

Type	Chemicals
Clone
Specific against	Other
Appl.	other
Host
Item no.	DCC-DC60282-250mg
Amount	250 mg
Available

Potassium Channel Activator 1

Type	Chemicals
Clone
Specific against	Other
Appl.	other
Host
Item no.	DCC-DC60282-1g
Amount	1 g
Available

L-Methionine sulfoxide

Type	Chemicals
Clone
Specific against	Other
Appl.	L-Methionine sulfoxide (H-Met(O)-OH), a metabolite of Methionine, induces M1/classical macrophage polarization, and modulates oxidative stress and purinergic signaling parameters.
Host
Item no.	DCC-DC29170-100mg
Amount	100 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk